HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR. 

First Page		Document Content
Date: 2015-03-26 19:23:33 Guanidines Anti-diabetic drugs Organic chemistry Diabetes Thiazolidinediones Metformin Sitagliptin Anti-diabetic medication Sulfonylurea Chemistry Medicine Biguanides		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR.  Add to Reading List Source URL: www.merck.com Download Document from Source Website File Size: 380,77 KB Share Document on Facebook

	SPECIAL AUTHORIZATION REQUEST DPP-4/SGLT2 INHIBITORS Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – PRESCRIBER INFORMATION DocID: 1pr3h - View Document
	Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES DocID: 1oY1K - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA™ (sitagliptin) Table DocID: 1dJB9 - View Document
	Patient Information JANUVIA™ (jah-NEW-vee-ah) (sitagliptin) Tablets Read the Patient Information that comes with JANUVIA* before you start taking it and each time you get a refill. There may be new information. This le DocID: 1anBo - View Document
	Cardiovascular Pipeline April 6, 2010 DocID: 1amKm - View Document